BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1465875)

  • 1. Low-dose OKT3 for cadaveric renal transplantation.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2592-3. PubMed ID: 1465875
    [No Abstract]   [Full Text] [Related]  

  • 2. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.
    Peces R; Urra JM; Gorostidi M; López-Larrea C
    Transplant Proc; 1992 Dec; 24(6):2596-9. PubMed ID: 1465877
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for granulocyte activation by OKT3.
    Schmaldienst S; Böhmig G; Pohanka E; Kovarik J; Zlabinger GJ
    Transplant Proc; 1992 Dec; 24(6):2600-1. PubMed ID: 1465878
    [No Abstract]   [Full Text] [Related]  

  • 5. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of ATG and OKT3 in renal allograft recipients.
    Spieker C; Barenbrock M; Buchholz B; Heidenreich S; Zidek W
    Transplant Proc; 1992 Dec; 24(6):2594-5. PubMed ID: 1465876
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract]   [Full Text] [Related]  

  • 9. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

  • 10. Pentamidine inhalation as a prophylaxis against Pneumocystis carinii pneumonia after therapy of acute renal allograft rejection with orthoclone (OKT3).
    Spieker C; Barenbrock M; Tepel M; Buchholz B; Rahn KH; Zidek W
    Transplant Proc; 1992 Dec; 24(6):2602-3. PubMed ID: 1465879
    [No Abstract]   [Full Text] [Related]  

  • 11. Area under the curve of cyclosporine pharmacokinetics: comparison of the characteristics of the pure drug and metabolites.
    Foradori AC; Martínez L; Vacarezza A; Elberg A; Mella G; Loveluck A; Pinto C
    Transplant Proc; 1992 Dec; 24(6):2614-5. PubMed ID: 1465884
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
    Morgan JD; Horsburgh T; Simpson A; Donnelly PK; Veitch PS; Bell PR
    Transplant Proc; 1992 Dec; 24(6):2634-5. PubMed ID: 1334589
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
    Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
    Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants.
    Schweizer RT; Bartus S; Hull D; Perdrizet G; Roper L
    Transplant Proc; 1994 Dec; 26(6):3141. PubMed ID: 7998094
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine-related hypercoagulability: fact or fiction?
    Edwards CM; Morgan JD; Donnelly PK
    Transplant Proc; 1992 Dec; 24(6):2616-7. PubMed ID: 1465885
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
    Carrier M; Jenicek M; Pelletier LC
    Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract]   [Full Text] [Related]  

  • 18. Measures to improve early results in kidney transplantation.
    Schweizer RT; Roper L; Hull D; Bartus S
    Transplant Proc; 1992 Dec; 24(6):2729-30. PubMed ID: 1465919
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose OKT3 induction therapy following renal transplantation leads to improved graft function and decreased adverse effects.
    Brown M; Korb S; Light JA; Light T; Jonsson J; Aquino A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):553-5. PubMed ID: 8438411
    [No Abstract]   [Full Text] [Related]  

  • 20. Living-unrelated renal transplantation.
    Simforoosh N; Bassiri A; Amiransari B; Gol S
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.